129 related articles for article (PubMed ID: 6419558)
1. Brain parenchyma penetration by intrathecal nonionic iopamidol.
Sage MR; Wilcox J
AJNR Am J Neuroradiol; 1983; 4(6):1181-3. PubMed ID: 6419558
[TBL] [Abstract][Full Text] [Related]
2. Brain parenchyma penetration by intrathecal ionic and nonionic contrast media.
Sage MR; Wilcox J; Evill CA; Benness GT
AJNR Am J Neuroradiol; 1982; 3(5):481-3. PubMed ID: 6814212
[TBL] [Abstract][Full Text] [Related]
3. Comparison of blood-brain barrier disruption by intracarotid iopamidol and methylglucamine iothalamate.
Sage MR; Wilcox J; Evill CA; Benness GT
AJNR Am J Neuroradiol; 1983; 4(4):893-5. PubMed ID: 6410875
[TBL] [Abstract][Full Text] [Related]
4. Iotrol, a new myelographic agent: 1. Radiography, CT, CSF clearance, and brain penetration.
Kerber CW; Sovak M; Ranganathan RS; Heilman CB
AJNR Am J Neuroradiol; 1983; 4(3):317-8. PubMed ID: 6410732
[TBL] [Abstract][Full Text] [Related]
5. Visual evoked response changes following intrathecal injection of water-soluble contrast media: a possible method of assessing neurotoxicity and a comparison of metrizamide and iopamidol.
Broadbridge AT; Bayliss SG; Firth R; Farrell G
Clin Radiol; 1984 Sep; 35(5):371-3. PubMed ID: 6547888
[TBL] [Abstract][Full Text] [Related]
6. Iopamidol and metrizamide in cervical myelography: side effects, EEG, and CSF changes.
Moschini L; Manara O; Bonaldi G; Cassinari V; Quilici N; Belloni G
AJNR Am J Neuroradiol; 1983; 4(3):848-50. PubMed ID: 6410870
[TBL] [Abstract][Full Text] [Related]
7. A double-blind clinical trial of iopamidol versus metrizamide for lumbosacral myelography.
Drayer BP; Vassallo C; Sudilovsky A; Luther JS; Wilkins RH; Allen S; Bates M
J Neurosurg; 1983 Apr; 58(4):531-7. PubMed ID: 6338167
[TBL] [Abstract][Full Text] [Related]
8. Elimination kinetics of iopamidol, a new water soluble nonionic radiographic contrast medium, analyzed by radioactivation.
Muratore O; Saitta S; Mallarini G; Corvisiero P; Sanzone M
Experientia; 1983 Jan; 39(1):119-21. PubMed ID: 6825773
[TBL] [Abstract][Full Text] [Related]
9. Radiopaque contrast media. XLVI - Preliminary studies of the metabolism of iopamidol in the dog, the rabbit and man.
Pitrè D; Tirone P; Viviani G
Farmaco Sci; 1980 Oct; 35(10):826-35. PubMed ID: 7450018
[TBL] [Abstract][Full Text] [Related]
10. Urinary excretion of Iopamidol following intrathecal administration.
Pitrè D; Zingales MF; Trevisan C
Neuroradiology; 1983; 25(1):37-8. PubMed ID: 6687926
[TBL] [Abstract][Full Text] [Related]
11. Elimination of aqueous myelographic contrast media from the subarachnoid space.
Eldevik OP; Haughton VM; Sasse EA
Invest Radiol; 1980; 15(6 Suppl):S260-3. PubMed ID: 7203932
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with iopamidol for myelography.
Bockenheimer SA; Hillesheimer W
AJNR Am J Neuroradiol; 1983; 4(3):314-6. PubMed ID: 6410731
[TBL] [Abstract][Full Text] [Related]
13. CT-determined canine kidney and urine iodine concentration following intravenous administration of sodium diatrizoate, metrizamide, iopamidol, and sodium ioxaglate.
Brennan RE; Rapoport S; Weinberg I; Pollack HM; Curtis JA
Invest Radiol; 1982; 17(1):95-100. PubMed ID: 7076442
[TBL] [Abstract][Full Text] [Related]
14. Iopamidol: new preclinical and clinical data.
Bonati F; Felder E; Tirone P
Invest Radiol; 1980; 15(6 Suppl):S310-6. PubMed ID: 7203941
[TBL] [Abstract][Full Text] [Related]
15. Safety of contrast media in cerebral angiography: iopamidol vs. methylglucamine iothalamate.
Bird CR; Drayer BP; Velaj R; Triolo PJ; Allen S; Bates M; Yeates AE; Heinz ER; Osborne DR
AJNR Am J Neuroradiol; 1984; 5(6):801-3. PubMed ID: 6437183
[TBL] [Abstract][Full Text] [Related]
16. Comparison of blood-brain barrier disruption in the rabbit following intracarotid iopamidol and methylglucamine iothalamate.
Wycherley AG; Wilcox J; Sage MR
Australas Radiol; 1984 Nov; 28(4):294-6. PubMed ID: 6535564
[No Abstract] [Full Text] [Related]
17. Rate of clearance of intrathecal iopamidol in the dog.
Wilcox J; Evill CA; Sage MR
Neuroradiology; 1986; 28(4):359-61. PubMed ID: 3762917
[TBL] [Abstract][Full Text] [Related]
18. [Side effects and contrast medium resorption of iopamidol and iocarmate in lumbar myelography].
Stoeter P; Bergleiter R; Schneider I; Kubina FG
Computertomographie; 1982 Dec; 2(4):179-83. PubMed ID: 6821243
[TBL] [Abstract][Full Text] [Related]
19. Comparison of radiographic quality and adverse reactions in myelography with iopamidol and metrizamide.
Bannon KR; Braun IF; Pinto RS; Manuell M; Sudilovsky A; Kricheff II
AJNR Am J Neuroradiol; 1983; 4(3):312-3. PubMed ID: 6410730
[TBL] [Abstract][Full Text] [Related]
20. [Cervical myelography with water-soluble nonionic contrast media (metrizamide and iopamidol) (author's transl)].
Nuzzo G; Malaguti C; Mavilla L; Fagioli L; Trevisan C
Radiol Med; 1980 Apr; 66(4):211-4. PubMed ID: 7455231
[No Abstract] [Full Text] [Related]
[Next] [New Search]
